| 000 | 01929 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513112829.0 | ||
| 264 | 0 | _c19970310 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1997.15.2.535 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatts, M J | |
| 245 | 0 | 0 |
_aProgenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cFeb 1997 |
||
| 300 |
_a535-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntigens, CD34 |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukapheresis |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xadverse effects |
| 700 | 1 | _aSullivan, A M | |
| 700 | 1 | _aJamieson, E | |
| 700 | 1 | _aPearce, R | |
| 700 | 1 | _aFielding, A | |
| 700 | 1 | _aDevereux, S | |
| 700 | 1 | _aGoldstone, A H | |
| 700 | 1 | _aLinch, D C | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 15 _gno. 2 _gp. 535-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1997.15.2.535 _zAvailable from publisher's website |
| 999 |
_c9041634 _d9041634 |
||